URINARY EXCRETION OF PROFIBROTIC AND ANTIFIBROTIC GROWTH FACTORS IN TYPE 1 DIABETIC PATIENTS: THE RELATION WITH DIABETIC NEPHROPATHY
- 作者: Bondar I1, Klimontov V1, Parfentieva E1, Romanov V2, Nadeev A1
-
隶属关系:
- Novosibirsk State Medical University
- Diagnostic Laboratory «In vitro»
- 期: 卷 84, 编号 6 (2012)
- 页面: 36-40
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31045
- ID: 31045
如何引用文章
全文:
详细
作者简介
I Bondar
Novosibirsk State Medical UniversityChair of Endocrinology
V Klimontov
Novosibirsk State Medical University
Email: klimontov@mail.ru
Chair of Endocrinology
E Parfentieva
Novosibirsk State Medical UniversityChair of Endocrinology
V Romanov
Diagnostic Laboratory «In vitro»канд. мед. наук, зав. лаб. Novosibirsk
A Nadeev
Novosibirsk State Medical UniversityChair of Pathology
参考
- Шестакова М. В., Дедов И. И. Сахарный диабет и хроническая болезнь почек. М.: Мед. информ. агентство; 2009.
- Бондарь И. А., Климонтов В. В., Рогова И. П., Надеев А. П. Почки при сахарном диабете. Новосибирск: Изд-во НГТУ; 2008.
- Cortes P., Mogensen C. E., eds. Diabetic kidney. Totowa, New Jersey: Humana Press; 2006.
- Min D., Lyons J. G., Bonner J. et al. Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2009; 297 (5): 1229—1237.
- Strutz F. The role of FGF-2 in renal fibrogenesis. Front. Biosci. (Schol. Ed.) 2009; 1 (1): 125—131.
- Esposito C., Parrilla B., De Mauri A. et al. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int. 2005; 67 (6): 2143—2150.
- De Petris L., Hruska K. A., Chiechio S. Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol. Dial. Transplant. 2007; 22 (12): 3442—3450.
- Mitu G. M., Wang S., Hirschberg R. BP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am. J. Physiol. Renal Physiol. 2007; 293 (5): F1641—F1648.
- Mitu G., Hirschberg R. Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front. Biosci. 2008; 1 (13): 4726—4739.
- Strutz F., Zeisberg M., Hemmerlein B. et al. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int. 2000; 57 (4): 1521—1538.
- Esposito C., Parrilla B., De Mauri A. et al. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int. 2005; 67 (6): 2143—2150.
- Yeh C. H., Chang C. K., Cheng M. F. et al. Decrease of bone morphogenetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type 1-like diabetic rats. Horm. Metab. Res. 2009; 41 (8): 605—611.
- Mizuno S., Nakamura T. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2004; 286 (1): F134—F143.
- Vasko R., Koziolek M., Ikehata M. et al. Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts. Am. J. Physiol. Renal Physiol. 2009; 296 (6): F1452—F1463.
- Wang S. N., Lapage J., Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 2001; 12 (11): 2392-2399.
- Ceriello A., Ihnat M. A., Thorpe J. E. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J. Clin. Endocrinol. 2009; 94 (2): 410-415.
- Lind M., Oden A., Fahlen M., Eliasson B. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. Diabetologia 2010; 53 (6): 1093-1098.
- Torres D. D., Rossini M., Manno C. et al. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int. 2008; 73 (3): 327-333.
- Бондарь И. А., Климонтов В. В. Ранние маркеры диабетической нефропатии. Клин. нефрол. 2010; 2: 60-65.
- Нанчикеева М. Л., Козловская Л. В., Рамеев В. В. и др. Определение мочевых маркеров протеолиза/фибринолиза и фибриоангиогенеза в почке у больных гипертонической болезнью. Тер. арх. 2011; 6: 23—27.
- Okonogi H., Nishimura M., Utsunomiya Y. et al. Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin. Nephrol. 2001; 55 (5): 357—364.
- Araki S., Haneda M., Koya D. et al. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabet. Care 2010; 33 (8): 1805—1810.
- Morita M., Uchigata Y., Hanai K. et al. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes. Am. J. Kidney Dis. 2011; In press.